Ingen Technologies Inc (IGNT)

[chuck44l]

Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading Global Medical Device manufacturer focused in the $ 4 Billion Respiratory Market for the growing ageing and emerging markets for Home (DME), Hospital and Aviation Industries, announced today that the company has signed a national marketing contract with the Colorado based Medco Forum.

Healthcare professionals searching for the latest advancements in products and services turn to Medco Forum for answers. Their highly respected medical newsletter provides exclusive previews of the most recent technological and product innovations prior to each medical specialist's annual conference. Prepared with this advance knowledge, healthcare providers are better able to use the conference to discover the newest and best products and services for their patients.

The company will be on the front cover of the Medco Forum's Chest Physicians issue scheduled for October 2009. The circulation for Chest Physicians is 13,000 and includes all board certified and practicing chest physicians in the U.S. that manage most of the 23 million home oxygen patients. Medco Forum has guaranteed that the Ingen article and the Web based link will be the only one addressing this type of medical technology relating to the new Oxyview Nasal Cannula.

"The Medco Forum issue will reach the majority of Chest Physician's in the U.S., and these physicians manage most of the 23 million COPD patients that require home oxygen therapy and would use the new Oxyview Nasal Cannula. Our new product is more advanced compared to the conventional nasal cannula and offers leading edge technology for the home oxygen patient," stated Christopher Wirth, Chief Operations Officer.

"Ingen has strategically developed a sound marketing program to introduce the new Oxyview Nasal Cannula to the majority of the 23 million home oxygen patients and their physician. The ad saturation approach will aggressively and quickly brand the product within the respiratory industry. Our goal is to capture 5-10% market share in 12 months, with revenues approaching $200M and increased earnings for our shareholders. According to the most recent statistics, home oxygen patients use 2-4 nasal cannula's each month to avoid bacteria related problems. The new Oxyview Nasal Cannula is disposable and competitively priced," stated Thomas J. Neavitt, Chief Financial Officer.

The nasal cannula (NC) is a device used to deliver supplemental oxygen to a patient or person in need of extra oxygen. This device consists of a plastic tube which fits behind the ears, and a set of two prongs which are placed in the nostrils. Oxygen flows from these prongs. The nasal cannula is connected to an oxygen tank, a portable oxygen generator, or a wall connection in a hospital via a flow meter. The nasal cannula carries 1-6 liters of oxygen per minute. There are also infant or neonatal nasal cannulas which carry less than one liter per minute; these also have smaller prongs. The oxygen fraction provided to the patient ranges roughly from 24% to 35%. The nasal cannula was invented by Wilfred Jones and patented in 1949 by his employer, BOC.

http://www.ingen-tech.com/ovaiopurch.php

http://www.medcoforum.com/

About Ingen:

Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.

The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact:
Ingen Technologies, Inc.Chris [e-mail]